UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The silencing of SAAL1 suppresses pneumonia progression via modulating the NLR signaling pathway

Annals of translational medicine, 2022-10, Vol.10 (20), p.1128-1128

2022

Volltextzugriff (PDF)

LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020-11, Vol.23 (6), p.1018-1032

2020

Volltextzugriff (PDF)

All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells

BMC cancer, 2020-04, Vol.20 (1), p.315-9, Article 315

2020

Volltextzugriff (PDF)

Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial

Journal of thoracic oncology, 2022-04, Vol.17 (4), p.544-557

2022

Volltextzugriff (PDF)

Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma

Cancer Immunology, Immunotherapy, 2019-12, Vol.68 (12), p.1959-1969

2019

Volltextzugriff (PDF)

A study on the anti-tumor mechanism of total flavonoids from Radix Tetrastigmae against additional cell line based on COX-2-mediated Wnt/β-catenin signaling pathway

Oncotarget, 2017-08, Vol.8 (33), p.54304-54319

2017

Volltextzugriff (PDF)

On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial

Molecular cancer, 2022-01, Vol.21 (1), p.4-4, Article 4

2022

Volltextzugriff (PDF)

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2022-06, Vol.23 (6), p.739-747

2022

Volltextzugriff (PDF)

A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma

Frontiers in oncology, 2022-11, Vol.12, p.1024915-1024915

2022

Volltextzugriff (PDF)

β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation

Frontiers in oncology, 2021-10, Vol.11, p.747282-747282

2021

Volltextzugriff (PDF)

Multi‑parameter quantitative magnetic resonance imaging in the early assessment of radiation‑induced parotid damage in patients with nasopharyngeal carcinoma following intensity‑modulated radiotherapy

Oncology letters, 2024-04, Vol.27 (4), Article 180

2024

Volltextzugriff (PDF)

Patient-derived primary breast cancer cells and their potential for predicting sensitivity to chemotherapy

Frontiers in oncology, 2022-10, Vol.12, p.1023391-1023391

2022

Volltextzugriff (PDF)

Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations

The lancet oncology, 2020-02, Vol.21 (2), p.306-316

2020

Volltextzugriff (PDF)

A prognostic gene signature for gastric cancer and the immune infiltration-associated mechanism underlying the signature gene, PLG

Clinical & translational oncology, 2023-04, Vol.25 (4), p.995-1010

2023

Volltextzugriff (PDF)

Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: A meta-analysis

Molecular and clinical oncology, 2018-03, Vol.8 (3), p.483-488

2018

Volltextzugriff (PDF)

Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer

Thoracic cancer, 2023-12, Vol.14 (34), p.3421-3429

2023

Volltextzugriff (PDF)

Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer

Thoracic cancer, 2024-02, Vol.15 (5), p.419-426

2024

Volltextzugriff (PDF)

HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non-Small Cell Lung Cancer

Clinical cancer research, 2023-12, Vol.29 (23), p.4830-4843

2023

Volltextzugriff (PDF)

Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies

Lung cancer (Amsterdam, Netherlands), 2023-06, Vol.180, p.107194-107194, Article 107194

2023

Volltextzugriff (PDF)

Total flavones from Sceptridium ternatum alleviate pulmonary hypertension through inhibiting the proliferation of vascular endothelial cells

Annals of translational medicine, 2022-06, Vol.10 (12), p.677-677

2022

Volltextzugriff (PDF)

Investigation on the prevalence and influencing factors of myopia among children and adolescents in Liyang city

American journal of translational research, 2022-01, Vol.14 (10), p.7164-7171

2022

Volltextzugriff (PDF)

Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES)

Lung cancer (Amsterdam, Netherlands), 2024-02, Vol.188, p.107455-107455, Article 107455

2024

Volltextzugriff (PDF)

Safety and Preliminary Efficacy of Ceritinib 450 mg with Food in Chinese ALK-positive Non-small Cell Lung Cancer

Zhongguo fei ai za zhi, 2020-08, Vol.23 (8), p.655-661

2020

Volltextzugriff (PDF)

Two SNPs of ATP-binding cassette B1 gene on the risk and prognosis of colorectal cancer

International journal of clinical and experimental pathology, 2015-01, Vol.8 (3), p.3083-3089

2015

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Journals Complete

Zeitschrift / SerieScientific Reports

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(28)

Sprache

Englisch
(27)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Humans
(14)
Chemotherapy
(9)
Prognosis
(7)
Lung Cancer
(6)
Lung Neoplasms - Pathology
(6)
Mutation
(6)
Respiratory System
(6)
Carcinoma, Non-Small-Cell Lung - Pathology
(5)
Female
(5)
Immunotherapy
(5)
Lung Neoplasms - Drug Therapy
(5)
Male
(5)
Medical Research
(5)
Original
(5)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(4)
Carcinoma, Non-Small-Cell Lung - Genetics
(4)
Lung Neoplasms - Genetics
(4)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The silencing of SAAL1 suppresses pneumonia progression via modulating the NLR signaling pathway

LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1

All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells

Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial

Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma

A study on the anti-tumor mechanism of total flavonoids from Radix Tetrastigmae against additional cell line based on COX-2-mediated Wnt/β-catenin signaling pathway

On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma

β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation

Multi‑parameter quantitative magnetic resonance imaging in the early assessment of radiation‑induced parotid damage in patients with nasopharyngeal carcinoma following intensity‑modulated radiotherapy

Patient-derived primary breast cancer cells and their potential for predicting sensitivity to chemotherapy

Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations

A prognostic gene signature for gastric cancer and the immune infiltration-associated mechanism underlying the signature gene, PLG

Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: A meta-analysis

Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer

Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer

HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non-Small Cell Lung Cancer

Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies

Total flavones from Sceptridium ternatum alleviate pulmonary hypertension through inhibiting the proliferation of vascular endothelial cells

Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study

Investigation on the prevalence and influencing factors of myopia among children and adolescents in Liyang city

Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES)

Safety and Preliminary Efficacy of Ceritinib 450 mg with Food in Chinese ALK-positive Non-small Cell Lung Cancer

Two SNPs of ATP-binding cassette B1 gene on the risk and prognosis of colorectal cancer

Aktive Filter

Suchergebnisse filtern